Inventor · disambiguated record
Martin G. Pomper
Also filed as: POMPER MARTIN · POMPER MARTIN G · POMPER MARTIN GILBERT
65 granted patents·65 pending applications·501 citations·filing 2003–2025
98Inventor score
Files withUNIV JOHNS HOPKINS110POMPER MARTIN G5POMPER MARTIN GILBERT4POMPER MARTIN3UNIV VIRGINIA COMMONWEALTH2
Top patents by PatentIndex Score
130 records- 0198US9226981B2PSMA-binding agents and uses thereofUNIV JOHNS HOPKINS·Filed 2014·Granted Jan 5, 2016·54 cites·16 claims
- 0298US8778305B2PSMA-binding agents and uses thereofPOMPER MARTIN·Filed 2009·Granted Jul 15, 2014·100 cites·18 claims
- 0397US9694091B2Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agentsUNIV JOHNS HOPKINS·Filed 2015·Granted Jul 4, 2017·19 cites·19 claims
- 0496US11661402B2PSMA-targeting compounds and uses thereofUNIV JOHNS HOPKINS·Filed 2022·Granted May 30, 2023·3 cites·19 claims
- 0596US11021450B2PSMA targeted fluorescent agents for image guided surgeryUNIV JOHNS HOPKINS·Filed 2020·Granted Jun 1, 2021·4 cites·21 claims
- 0696US9776977B2PSMA-targeting compounds and uses thereofUNIV JOHNS HOPKINS·Filed 2014·Granted Oct 3, 2017·14 cites·7 claims
- 0796US9056841B2PSMA-targeting compounds and uses thereofPOMPER MARTIN·Filed 2010·Granted Jun 16, 2015·48 cites·3 claims
- 0895US10039845B2Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agentsUNIV JOHNS HOPKINS·Filed 2017·Granted Aug 7, 2018·7 cites·18 claims
- 0994US9044468B2Labeled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agentsPOMPER MARTIN G·Filed 2008·Granted Jun 2, 2015·46 cites·4 claims
- 1093US9861713B2PSMA-binding agents and uses thereofUNIV JOHNS HOPKINS·Filed 2016·Granted Jan 9, 2018·9 cites·12 claims
- 1193US7408079B2Imaging agents and methods of imaging NAALADase or PSMAUNIV JOHNS HOPKINS·Filed 2003·Granted Aug 5, 2008·51 cites·28 claims
- 1292US10736974B2Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapyUNIV JOHNS HOPKINS·Filed 2015·Granted Aug 11, 2020·4 cites·1 claims
- 1392US10717750B268Ga-labeled NOTA-chelated PSMA-targeted imaging and therapeutic agentsUNIV JOHNS HOPKINS·Filed 2016·Granted Jul 21, 2020·4 cites·12 claims
- 1492US8227634B2Imaging agents and methods of imaging NAALADase or PSMAPOMPER MARTIN GILBERT·Filed 2008·Granted Jul 24, 2012·38 cites·16 claims
- 1592US2025177578A1Psma-binding agents and uses thereofUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 1691US10683272B2Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapyUNIV JOHNS HOPKINS·Filed 2015·Granted Jun 16, 2020·5 cites·20 claims
- 1791US10500292B2PSMA-binding agents and uses thereofUNIV JOHNS HOPKINS·Filed 2018·Granted Dec 10, 2019·6 cites·4 claims
- 1890US9884132B2Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereofUNIV JOHNS HOPKINS·Filed 2016·Granted Feb 6, 2018·9 cites·13 claims
- 1989US10688198B2Salicylic acid-based polymeric CEST contrast agents targeting prostate-specific membrane antigen and uses thereofUNIV JOHNS HOPKINS·Filed 2016·Granted Jun 23, 2020·4 cites·40 claims
- 2089US10653806B2Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereofUNIV JOHNS HOPKINS·Filed 2018·Granted May 19, 2020·4 cites·8 claims
- 2189US10232058B2Prostate-specific membrane antigen-targeted photosensitizers for photodynamic therapyUNIV JOHNS HOPKINS·Filed 2014·Granted Mar 19, 2019·6 cites·14 claims
- 2288US9371360B2Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereofUNIV JOHNS HOPKINS·Filed 2012·Granted Jun 21, 2016·12 cites·5 claims
- 2387US11813340B2PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2019·Granted Nov 14, 2023·2 cites·31 claims
- 2487US10947197B2Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [18F]DCFPyLUNIV JOHNS HOPKINS·Filed 2017·Granted Mar 16, 2021·3 cites·33 claims
- 2587US9422234B2Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancerCHANDRAN SACHIN S·Filed 2008·Granted Aug 23, 2016·14 cites·26 claims
- 2685US10369113B2Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancerUNIV JOHNS HOPKINS·Filed 2016·Granted Aug 6, 2019·4 cites·19 claims
- 2784US9498546B2Synthesis and application of novel imaging agents conjugated to DPA 713 analogs for imaging inflammationUNIV JOHNS HOPKINS·Filed 2013·Granted Nov 22, 2016·5 cites·12 claims
- 2884US2025230135A1Metal/radiometal-labeled psma inhibitors for psma-targeted imaging and radiotherapyUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 2983US12115233B2Imaging and radiotherapeutics agents targeting fibroblast-activation protein-α (FAP-α)UNIV JOHNS HOPKINS·Filed 2024·Granted Oct 15, 2024·0 cites·4 claims
- 3083US2025186628A1Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (fap-alpha)UNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 3183US2025195700A1Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancerUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 3282US11458213B2Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancerUNIV JOHNS HOPKINS·Filed 2017·Granted Oct 4, 2022·1 cites·14 claims
- 3381US11478558B2Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancerUNIV JOHNS HOPKINS·Filed 2018·Granted Oct 25, 2022·1 cites·12 claims
- 3481US10029023B2Theranostic imaging agents and methods of usePOMPER MARTIN·Filed 2012·Granted Jul 24, 2018·10 cites·13 claims
- 3580US12070513B2PSMA-binding agents and uses thereofUNIV JOHNS HOPKINS·Filed 2021·Granted Aug 27, 2024·0 cites·23 claims
- 3680US11938201B2Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (FAP-alpha)UNIV JOHNS HOPKINS·Filed 2023·Granted Mar 26, 2024·0 cites·3 claims
- 3779US8273326B2Imaging infection with compounds that bind to thymidine kinasePOMPER MARTIN G·Filed 2005·Granted Sep 25, 2012·1 cites·21 claims
- 3879US2023348405A1Psma-targeting compounds and uses thereofUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 3978US12233137B1PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2023·Granted Feb 25, 2025·0 cites·20 claims
- 4078US12165036B2Methods and related aspects for pathology prognosisUNIV JOHNS HOPKINS·Filed 2023·Granted Dec 10, 2024·0 cites·20 claims
- 4178US2024370700A1Methods and related aspects for pathology prognosisUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 4277US2025177580A1Psma targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 4376US8691186B2Imaging infection with compounds that bind to thymidine kinasePOMPER MARTIN G·Filed 2012·Granted Apr 8, 2014·1 cites·8 claims
- 4475US12065413B2PSMA targeted fluorescent agents for image guided surgeryUNIV JOHNS HOPKINS·Filed 2021·Granted Aug 20, 2024·0 cites·19 claims
- 4575US10426850B2Collagen mimetic peptides for targeting collagen strands for in vitro and in vivo imaging and therapeutic useUNIV JOHNS HOPKINS·Filed 2012·Granted Oct 1, 2019·4 cites·13 claims
- 4675US2025235565A1Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (fap-alpha)UNIV JOHNS HOPKINS·Filed 2025·Application pending·0 cites
- 4775US2024140971A1Psma targeted radiohalogenated ureas for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 4875US2023015736A1Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancerUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 4974US2025162993A1Synthesis of the radiolabeled prostate-specific membrane antigen (psma) inhibitor [18f]dcfpylUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 5074US2022135529A1Metal/radiometal-labeled psma inhibitors for psma-targeted imaging and radiotherapyUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
Showing the top 50 of 130 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Martin G. Pomper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →